Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Le Lorier

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
C.H.A.C. Review|March 6, 1985
The how and why of ethics committees ... in a research unit--MontrealJ Le Lorier
L'Union Medicale Du Canada|June 1, 1981
[Adrenergic beta receptor blocking drugs]P Larochelle, J Le Lorier
BMJ (Clinical Research Ed.)|February 24, 1998
Meta-analysis and the meta-epidemiology of clinical research. Comments on paper by author of editorial were unwarrantedJ Le Lorier, G Grégoire
Journal of Human Hypertension|February 1, 1996
How to assess the economics of hypertension control programmesM Johannesson, J Le Lorier
The Canadian Journal of Clinical Pharmacology = Journal Canadien De Pharmacologie Clinique|October 25, 2000
Efficacy and cost of HMG-CoA reductase inhibitors in the treatment of patients with primary hyperlipidemiaS Perreault, C Levinton, J Le Lorier
Journal of Clinical Epidemiology|January 1, 1995
Selecting the language of the publications included in a meta-analysis: is there a Tower of Babel bias?G Grégoire, F Derderian, J Le Lorier
L'Union Medicale Du Canada|March 1, 1995
[Gastroesophageal reflux (round table II)]R Lahaie, C Laroche, M Boivin, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|August 27, 1999
Reference-based pricing of prescription drugs: exploring the equivalence of angiotensin-converting-enzyme inhibitorsC Bourgault, E Elstein, J Le Lorier, et al.
Journal De Gynecologie, Obstetrique Et Biologie De La Reproduction|January 1, 1986
[Study of peripheral resistance in pregnant women. Preliminary results]E Rey, F Joyal, J M Moutquin, et al.
Pharmacoepidemiology and Drug Safety|January 5, 2002
Antihypertensives and myocardial infarction risk: the modifying effect of history of drug useC Bourgault, E Elstein, M A Baltzan, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
C.H.A.C. Review|March 6, 1985
The how and why of ethics committees ... in a research unit--MontrealJ Le Lorier
L'Union Medicale Du Canada|June 1, 1981
[Adrenergic beta receptor blocking drugs]P Larochelle, J Le Lorier
BMJ (Clinical Research Ed.)|February 24, 1998
Meta-analysis and the meta-epidemiology of clinical research. Comments on paper by author of editorial were unwarrantedJ Le Lorier, G Grégoire
Journal of Human Hypertension|February 1, 1996
How to assess the economics of hypertension control programmesM Johannesson, J Le Lorier
The Canadian Journal of Clinical Pharmacology = Journal Canadien De Pharmacologie Clinique|October 25, 2000
Efficacy and cost of HMG-CoA reductase inhibitors in the treatment of patients with primary hyperlipidemiaS Perreault, C Levinton, J Le Lorier
Journal of Clinical Epidemiology|January 1, 1995
Selecting the language of the publications included in a meta-analysis: is there a Tower of Babel bias?G Grégoire, F Derderian, J Le Lorier
L'Union Medicale Du Canada|March 1, 1995
[Gastroesophageal reflux (round table II)]R Lahaie, C Laroche, M Boivin, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|August 27, 1999
Reference-based pricing of prescription drugs: exploring the equivalence of angiotensin-converting-enzyme inhibitorsC Bourgault, E Elstein, J Le Lorier, et al.
Journal De Gynecologie, Obstetrique Et Biologie De La Reproduction|January 1, 1986
[Study of peripheral resistance in pregnant women. Preliminary results]E Rey, F Joyal, J M Moutquin, et al.
Pharmacoepidemiology and Drug Safety|January 5, 2002
Antihypertensives and myocardial infarction risk: the modifying effect of history of drug useC Bourgault, E Elstein, M A Baltzan, et al.
Pageof 2